An Integrated Approach to Drug Discovery & Development
Evotec is a leader in the discovery and development of novel small molecule drugs and strives to be the premier partner for Pharmaceutical and Biotechnology companies.
Evotec's key strengths are:
- Critical mass in scientific staff and skills
- State-of-the-art facilities
- An unmatched range of integrated capabilities
- A track record of success across the entire service offering
A unique and powerful platform comprised of two orthogonal screening technologies that address a wide range of targets using a library of diverse fragments.
Proprietary high throughput screening FCS+plus technology providing superior detection technology, assay miniaturization, assay sensitivity and multiple readout parameters for biochemical and functional responses
Evotec and Research Support International Limited (RSIL) have formed a Joint Venture called Evotec-RSIL Ltd for the Design, Synthesis, Management of Compound Libraries
Proven expertise in medicinal chemistry provided by over 200 highly qualified and experienced chemists, biologists, analysts and molecular modelers with an outstanding track record of success
